AlphAIalphai — Financial news for AI agents
gurufocus.comAUG 271 min read$BBWI

BBWI Maintains by Morgan Stanley -- Price Target Lowered to $20

Morgan Stanley maintained its 'Equal-Weight' rating on Bath & Body Works (BBWI) but lowered its price target from $22 to $20. GuruFocus values BBWI at $34.04, suggesting a 44.5% undervaluation. The company has a GF Score of 66, indicating solid performance but challenges in growth and financial strength.

Original reporting
gurufocus.com
Published Aug 27, 2026, 1:50 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 27, 2026, 4:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefFinancial news
Primary signal
$BBWI
Bearish
medium confidence
Mentioned
$BBWI
Relevance
4/10
alphai data visualization · based on gurufocus.com
Decision brief

The 30-second read

$BBWIBearishLow
01

Why it matters

Analyst target reduction signals caution but does not introduce a new catalyst; price may remain range-bound.

02

Market read

Analyst rating update with modest target cut; limited trading relevance.

03

What to watch

Potential upside from digital expansion and international growth not reflected in the target.

Relevance 4/10Novelty 4/10Timing: no immediate time-sensitive catalyst

Background

BBWI is a specialty home fragrance retailer with a market cap of ~$3.8B, currently trading around $18.90.

Company-level read

Ticker impact

$BBWIBearishMedium confidence
Context

Morgan Stanley maintained its Equal-Weight rating on BBWI and lowered the price target to $20, reflecting a cautious outlook.

Expected impact

Slight price decline or sideways trading until new catalyst.

Evidence & confidence

Analyst target cuts often lead to short-term price pressure, but no immediate catalyst is present.

Market effects

Sector

Minimal impact on the consumer cyclical retail sector.

Regional

Limited to US retail investors.

Global

Low

Counterpoint

What could challenge this read

The price target cut may be overly cautious given the stock's valuation discount.

Key entities

  • Analyst
    Morgan Stanley

    Equity research firm providing rating and price target.

Read at source← All news

Related articles

AUG 28
$BBWIMedAI 8/10

Bath & Body Works, Inc. Q2 2027 Earnings Call Summary

Bath & Body Works reported Q2 2027 sales beat due to digital growth and expanded distribution. The company is shifting focus to enduring franchises and exiting the Home Care category. Digital sales improved, and management reinvested $35M in marketing. Guidance was narrowed, assuming macro pressures persist. Q2 results included an $80M tariff refund benefit. Management discussed sustainability of digital growth, store traffic strategies, and partnerships with Amazon and Ulta.

yahoo.com3 min
AUG 27
$BBWIMedAI 8/10

Bath & Body Works Q2 Earnings Call Highlights

Bath & Body Works reported Q2 sales of $1.1 billion, down 5.4% YoY, with direct-channel sales up 3% and international revenue up 24.9%. The company's digital business grew, and new product launches exceeded expectations. Bath & Body Works plans to exit its home-care category and expand distribution with Amazon and Ulta. It narrowed its full-year sales outlook to a decline of 2.5% to 4% and raised adjusted EPS guidance to $2.60 to $2.80.

yahoo.com2 min
AUG 27
$BBWIHighAI 8/10

Bath & Body Works lifts full-year earnings outlook after Q2 profit beats forecasts

Bath & Body Works (BBWI) reported Q2 earnings of $0.62 per share, beating estimates of $0.24, with revenue at $1.5B, down 2.3% YoY. The company raised full-year EPS guidance to $2.60-$2.80 but issued a cautious Q3 outlook, expecting sales to decline 2.5%-5% and EPS to be $0.07-$0.12, below estimates of $0.26. CEO Daniel Heaf noted early progress in their Consumer First strategy.

yahoo.com2 min
AUG 27
$BBWIMedAI 8/10

Bath & Body Works Q2 net sales fall amid weak underlying demand

Bath & Body Works reported Q2 net sales of $1.51bn, down 2.3% YoY, but higher operating income ($216m) and net income ($118m). CEO Daniel Heaf noted sequential improvements in body care and digital sales, while raising full-year 2026 EPS outlook to $3.13-$3.33. The company expects Q3 sales to decline 5-2.5% with adjusted EPS at $0.07-$0.12.

yahoo.com2 min
AUG 27
$BBWIHighAI 8/10

BBWI Q2 2027 Earnings Call Transcript

Bath & Body Works (BBWI) reported Q2 2027 revenue of $1.5B, down 2.3% YoY. Adjusted EPS was $0.62, beating guidance. Tariff refunds contributed $80M. Full-year sales guidance narrowed to -4% to -2.5%, while adjusted EPS guidance raised to $2.60-$2.80. Digital sales grew 3%, first increase since 2021. International sales rose 24.9%. Management warned of future cost pressures and noted store traffic challenges.

fool.com3 min